Citation Impact
Citing Papers
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
2004 Standout
Genome-wide features of neuroendocrine regulation in Drosophila by the basic helix-loop-helix transcription factor DIMMED
2015 StandoutNobel
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
2009 StandoutNobel
α7 Neuronal Nicotinic Acetylcholine Receptors Are Negatively Regulated by Tyrosine Phosphorylation and Src-Family Kinases
2005
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
MYC on the Path to Cancer
2012 Standout
Adverse Health Effects of Marijuana Use
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore
2008
SOCS proteins, cytokine signalling and immune regulation
2007 Standout
Inhibitors of Protein Tyrosine Phosphatases: Next‐Generation Drugs?
2005
TGF-β: the master regulator of fibrosis
2016 Standout
Controlling cytokine signaling by constitutive inhibitors
2005
Head and neck cancer
2008 Standout
Physiology and immunology of the cholinergic antiinflammatory pathway
2007 Standout
Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis
2018
The pathogenesis of cardiac fibrosis
2013 Standout
Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes
2010
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
2-(Arylmethyl)-3-substituted quinuclidines as selective α7 nicotinic receptor ligands
2005
Pathophysiology of Diabetic Nephropathy: Involvement of Multifaceted Signalling Mechanism
2009
RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model
2008
The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism
2005
Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury
2004
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF
2005
Binding of S100 proteins to RAGE: An update
2008
Pathologic Classification of Diabetic Nephropathy
2010 Standout
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders
2016
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
2004 Standout
Reflex control of immunity
2009 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Glutaminolysis and Transferrin Regulate Ferroptosis
2015 Standout
The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress
2005
Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
2009
Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney
2005
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
2005 Standout
The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy
2006
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Synthesis of Selective Agonists for the α7 Nicotinic Acetylcholine Receptor with In Situ Click-Chemistry on Acetylcholine-Binding Protein Templates
2012 StandoutNobel
Selective α7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3β and decreases tau phosphorylation in vivo
2009
Alzheimer's Disease
2010 Standout
The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease
1999
Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
2016
Key Role of Src Kinase in S100B-induced Activation of the Receptor for Advanced Glycation End Products in Vascular Smooth Muscle Cells
2006
Diabetes and nephropathy
2003
Can the Protective Actions of JAK-STAT in the Heart be Exploited Therapeutically? Parsing the Regulation of Interleukin-6-Type Cytokine Signaling
2007
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
2007
The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
2009
Type 2 diabetes mellitus
2015 Standout
Cellular signalling of the receptor for advanced glycation end products (RAGE)
2013
Activation of Tubular Epithelial Cells in Diabetic Nephropathy and the Role of the Peroxisome Proliferator–Activated Receptor-γ Agonist
2006
Hepatocyte Growth Factor Antagonizes the Profibrotic Action of TGF-β1 in Mesangial Cells by Stabilizing Smad Transcriptional Corepressor TGIF
2004
Microvascular basement membranes in diabetes mellitus
2003
The myocardial JAK/STAT pathway: From protection to failure
2008
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
2006 Standout
Insight on the Pathogenesis of Diabetic Nephropathy from the Study of Podocyte and Mesangial Cell Biology
2005
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model
2004
Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist
2005
Transcriptional Paradigms in Mammalian Mitochondrial Biogenesis and Function
2008
NADPH oxidase in the vasculature: Expression, regulation and signalling pathways; role in normal cardiovascular physiology and its dysregulation in hypertension
2019
Multiple Pharmacophores for the Selective Activation of Nicotinic α7-Type Acetylcholine Receptors
2008
NAD + /NADH and NADP + /NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences
2007 Standout
Functions of S100 Proteins
2012
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Receptor‐mediated tobacco toxicity: cooperation of the Ras/Raf‐1/MEK1/ERK and JAK‐2/STAT‐3 pathways downstream of a7 nicotinic receptor in oral keratinocytes
2006
Sequential Follow-Up Results of Catheter Intervention for Coronary Artery Lesions After Kawasaki Disease
2002
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Inhibitoren der Proteintyrosinphosphatasen: Kandidaten für zukünftige Wirkstoffe?
2005
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
2017 Standout
Angiotensin II–Induced Insulin Resistance and Protein Tyrosine Phosphatases
2004
From Fibrosis to Sclerosis
2008
Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit
2011 StandoutScience
STAT5 Activation and Cardioprotection by Remote Ischemic Preconditioning in Humans
2011
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Non-Smad TGF-β signals
2005 Standout
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Mutation of the α2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine
2002 StandoutNobel
Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial Infarction
2004
Angiotensin II Enhances Interleukin-18 Mediated Inflammatory Gene Expression in Vascular Smooth Muscle Cells
2005
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Mechanisms of Diabetic Complications
2013 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Fluorosulfuryl Isocyanate Enabled SuFEx Ligation of Alcohols and Amines
2021 StandoutNobel
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
2013
Vascular targets for cannabinoids: animal and human studies
2013
Reactive Oxygen Species-Regulated Signaling Pathways in Diabetic Nephropathy
2003
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation
2009
DAMPs, PAMPs and alarmins: all we need to know about danger
2006 Standout
Works of Seán Shaw being referenced
Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries
2009
Janus Kinase 2, an Early Target of α7 Nicotinic Acetylcholine Receptor-mediated Neuroprotection against Aβ-(1–42) Amyloid
2002
Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose
2002
Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells
2006
The Neuroprotective Effect of 2-(3-Pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a Novel α7 Ligand, Is Prevented through Angiotensin II Activation of a Tyrosine Phosphatase
2004
Inhibition of the JAK/STAT Signaling Pathway Prevents the High Glucose-Induced Increase in TGF-β and Fibronectin Synthesis in Mesangial Cells
2002
Aldose reductase pathway mediates JAK‐STAT signaling: a novel axis in myocardial ischemic injury
2005
Salbutamol overcomes the effect of the noradrenergic neurotoxin DSP-4 on memory function in the day-old chick.
1997
High Glucose Augments the Angiotensin II-induced Activation of JAK2 in Vascular Smooth Muscle Cells via the Polyol Pathway
2003
Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1.
2003
Angiotensin II Blocks Nicotine-Mediated Neuroprotection against β-Amyloid (1-42) via Activation of the Tyrosine Phosphatase SHP-1
2003
Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli
2004
S100B-RAGE-Mediated Augmentation of Angiotensin II-Induced Activation of JAK2 in Vascular Smooth Muscle Cells Is Dependent on PLD2
2003
Function and expression of endothelin-converting enzyme-1 in human vascular smooth muscle
1998